159 related articles for article (PubMed ID: 38342025)
1. MTMR7 suppresses the phenotypic switching of vascular smooth muscle cell and vascular intimal hyperplasia after injury via regulating p62/mTORC1-mediated glucose metabolism.
Sun X; Yang Y; Zhao W; Wang M; Chen Y; Wang J; Yang D; Yang Y
Atherosclerosis; 2024 Mar; 390():117470. PubMed ID: 38342025
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of VRK1 suppresses proliferation and migration of vascular smooth muscle cells and intima hyperplasia after injury via mTORC1/β-catenin axis.
Sun X; Zhao W; Wang Q; Zhao J; Yang D; Yang Y
BMB Rep; 2022 May; 55(5):244-249. PubMed ID: 35410639
[TBL] [Abstract][Full Text] [Related]
3. Wild-type p53-induced phosphatase 1 promotes vascular smooth muscle cell proliferation and neointima hyperplasia after vascular injury via p-adenosine 5'-monophosphate-activated protein kinase/mammalian target of rapamycin complex 1 pathway.
Sun X; Li S; Gan X; Qiu C; Chen K; Pei H; Wang Q; Li D; Li X; Yang D; Yang Y
J Hypertens; 2019 Nov; 37(11):2256-2268. PubMed ID: 31136458
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of PIKfyve Ameliorates the Proliferation and Migration of Vascular Smooth Muscle Cells and Vascular Intima Hyperplasia By Reducing mTORC1 Activity.
Gu M; Wang Z; Feng F; Yang Y; Sun X; Yang D
J Cardiovasc Pharmacol; 2022 May; 79(5):739-748. PubMed ID: 35275098
[TBL] [Abstract][Full Text] [Related]
5. Glycolysis and de novo fatty acid synthesis cooperatively regulate pathological vascular smooth muscle cell phenotypic switching and neointimal hyperplasia.
Cao K; Zhang T; Li Z; Song M; Li A; Yan J; Guo S; Wang L; Huang S; Li Z; Hou W; Dai X; Wang Y; Feng D; He J; Fu X; Xu Y
J Pathol; 2023 Apr; 259(4):388-401. PubMed ID: 36640260
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of p90RSK Ameliorates PDGF-BB-Mediated Phenotypic Change of Vascular Smooth Muscle Cell and Subsequent Hyperplasia of Neointima.
Hwang AR; Lee HJ; Kim S; Park SH; Woo CH
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175802
[TBL] [Abstract][Full Text] [Related]
7. Ruxolitinib attenuates intimal hyperplasia via inhibiting JAK2/STAT3 signaling pathway activation induced by PDGF-BB in vascular smooth muscle cells.
Song HT; Cui Y; Zhang LL; Cao G; Li L; Li G; Jia XJ
Microvasc Res; 2020 Nov; 132():104060. PubMed ID: 32818511
[TBL] [Abstract][Full Text] [Related]
8. [Role of cytokine-matrix metalloproteinase axis on promoting vascular neointima hyperplasia in mice].
Liu Y; Ning WH; Shen XH; Guo DL; Guo L
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Nov; 44(11):961-967. PubMed ID: 27903395
[No Abstract] [Full Text] [Related]
9. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
[TBL] [Abstract][Full Text] [Related]
10. Galangin inhibits neointima formation induced by vascular injury
Wu B; Xu C; Ding HS; Qiu L; Gao JX; Li M; Xiong Y; Xia H; Liu X
Food Funct; 2022 Nov; 13(23):12077-12092. PubMed ID: 36367287
[No Abstract] [Full Text] [Related]
11. Role of Nuclear Receptor Subfamily 1 Group D Member 1 in the Proliferation, Migration of Vascular Smooth Muscle Cell, and Vascular Intimal Hyperplasia.
Wang M; Qiu C; Pan Q; Yang Y; Yang D; Sun X
J Cardiovasc Pharmacol; 2023 Sep; 82(3):221-228. PubMed ID: 37381169
[TBL] [Abstract][Full Text] [Related]
12. RhoGDI3 at the trans-Golgi network participates in NLRP3 inflammasome activation, VSMC phenotypic modulation, and neointima formation.
Sun J; Zhu Q; Yu X; Liang X; Guan H; Zhao H; Yao W
Atherosclerosis; 2023 Dec; 387():117391. PubMed ID: 38029612
[TBL] [Abstract][Full Text] [Related]
13. Plin5 inhibits proliferation and migration of vascular smooth muscle cell through interacting with PGC-1α following vascular injury.
Gan X; Zhao J; Chen Y; Li Y; Xuan B; Gu M; Feng F; Yang Y; Yang D; Sun X
Bioengineered; 2022 Apr; 13(4):10665-10678. PubMed ID: 35470759
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of smooth muscle cell ILF3 alleviates intimal hyperplasia via HMGB1 mRNA degradation-mediated regulation of the STAT3/DUSP16 axis.
Hou YM; Xu BH; Zhang QT; Cheng J; Zhang X; Yang HR; Wang ZY; Wang P; Zhang MX
J Mol Cell Cardiol; 2024 May; 190():62-75. PubMed ID: 38583797
[TBL] [Abstract][Full Text] [Related]
15. Regulation of autophagy by controlling Erk1/2 and mTOR for platelet-derived growth factor-BB-mediated vascular smooth muscle cell phenotype shift.
Han JH; Park HS; Lee DH; Jo JH; Heo KS; Myung CS
Life Sci; 2021 Feb; 267():118978. PubMed ID: 33412209
[TBL] [Abstract][Full Text] [Related]
16. Mindin regulates vascular smooth muscle cell phenotype and prevents neointima formation.
Zhu LH; Huang L; Zhang X; Zhang P; Zhang SM; Guan H; Zhang Y; Zhu XY; Tian S; Deng K; Li H
Clin Sci (Lond); 2015 Jul; 129(2):129-45. PubMed ID: 25751394
[TBL] [Abstract][Full Text] [Related]
17. Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS/NFκB/mTOR/P70S6K signaling cascade.
Lu QB; Wan MY; Wang PY; Zhang CX; Xu DY; Liao X; Sun HJ
Redox Biol; 2018 Apr; 14():656-668. PubMed ID: 29175753
[TBL] [Abstract][Full Text] [Related]
18. Role of polypyrimidine tract-binding protein 1/yin yang 2 signaling in regulating vascular smooth muscle cell proliferation and neointima hyperplasia.
Wang Z; Gan X; Qiu C; Yang D; Sun X; Zeng Z
Toxicol Appl Pharmacol; 2019 Nov; 383():114747. PubMed ID: 31499192
[TBL] [Abstract][Full Text] [Related]
19. Nuclear receptor subfamily 1 group D member 1 suppresses the proliferation, migration of adventitial fibroblasts, and vascular intimal hyperplasia via mammalian target of rapamycin complex 1/β-catenin pathway.
Peng K; Wang M; Wang J; Wang Q; Li D; Sun X; Yang Y; Yang D
Clin Exp Hypertens; 2023 Dec; 45(1):2178659. PubMed ID: 36794491
[TBL] [Abstract][Full Text] [Related]
20. AKAP1 alleviates VSMC phenotypic modulation and neointima formation by inhibiting Drp1-dependent mitochondrial fission.
Sun J; Shao Y; Pei L; Zhu Q; Yu X; Yao W
Biomed Pharmacother; 2024 Jul; 176():116858. PubMed ID: 38850669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
